Shih‐Ku Lin
Impact in
- Biological Psychiatry top 1%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 1%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
Papers in
-
- Schizophrenia research and treatment 51
- Bipolar Disorder and Treatment 34
- Epilepsy research and treatment 11
- Pharmacology 28
- Treatment of Major Depression 16
- Pharmacogenetics and Drug Metabolism 9
- Co-authors
- Ming‐Chyi Huang (26 shared papers)Michael W. Jann (20 shared papers)Wen‐Ho Chang (10 shared papers)David Ball (4 shared papers)El‐Wui Loh (4 shared papers)Robin Murray (4 shared papers)Pak C. Sham (4 shared papers)Chun‐Hung Pan (8 shared papers)
- Journals
- Psychiatry and Clinical Neurosciences (10 papers)Journal of Clinical Psychopharmacology (10 papers)The Journal of Clinical Psychiatry (6 papers)Substance Use & Misuse (4 papers)Drug and Alcohol Dependence (4 papers)
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Shih‐Ku Lin
122 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 126
- Biological Psychiatry 281
- Psychiatry and Mental health 1.3k
- Toxicology 215
- Cellular and Molecular Neuroscience 728
- Pharmacology 550
Countries citing papers authored by Shih‐Ku Lin
This map shows the geographic impact of Shih‐Ku Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shih‐Ku Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shih‐Ku Lin more than expected).
Fields of papers citing papers by Shih‐Ku Lin
This network shows the impact of papers produced by Shih‐Ku Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shih‐Ku Lin. The network helps show where Shih‐Ku Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Shih‐Ku Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 211 | |
| 2 | 1999 | 123 | |
| 3 | 2005 | 116 | |
| 4 | 2008 | 101 | |
| 5 | 2004 | 100 | |
| 6 | 2004 | 84 | |
| 7 | 1997 | 75 | |
| 8 | 1998 | 75 | |
| 9 | 2016 | 70 | |
| 10 | 2004 | 69 | |
| 11 | 2007 | 68 | |
| 12 | 2014 | 64 | |
| 13 | 2006 | 62 | |
| 14 | 2013 | 60 | |
| 15 | 2019 | 56 | |
| 16 | 2019 | 56 | |
| 17 | Clozapine dosages and plasma drug concentrations. | 1997 | 53 |
| 18 | 1996 | 50 | |
| 19 | 2003 | 49 | |
| 20 | 1993 | 47 |
About Shih‐Ku Lin
Shih‐Ku Lin is a scholar working on Psychiatry and Mental health, Pharmacology, Cellular and Molecular Neuroscience, Pediatrics, Perinatology and Child Health and Biological Psychiatry, having authored 126 papers that have together received 3.0k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (51 papers), Bipolar Disorder and Treatment (34 papers), Neurotransmitter Receptor Influence on Behavior (20 papers), Treatment of Major Depression (16 papers), Tryptophan and brain disorders (15 papers), Epilepsy research and treatment (11 papers), Substance Abuse Treatment and Outcomes (10 papers) and Pharmacogenetics and Drug Metabolism (9 papers). The work is most often cited by research in Biological Psychiatry (281 citations), Psychiatry and Mental health (1.3k citations), Toxicology (215 citations), Cellular and Molecular Neuroscience (728 citations) and Pharmacology (550 citations). Shih‐Ku Lin has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Ming‐Chyi Huang, Michael W. Jann, Wen‐Ho Chang, David Ball, El‐Wui Loh, Robin Murray, Pak C. Sham, Chun‐Hung Pan, Mong‐Liang Lu and Shao‐Chun Ree. Their work appears in journals such as Psychiatry and Clinical Neurosciences, Journal of Clinical Psychopharmacology, The Journal of Clinical Psychiatry, Substance Use & Misuse and Drug and Alcohol Dependence.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.